MPS Pharmaa Ltd | 7.61 Cr. | 3.98 | 4.33/3.05 | | 0.80 | 0.00 % | 9.15 % | 34.9 % | 10.0 |
Gujarat Themis Biosyn Ltd | 2,715 Cr. | 249 | 390/216 | 51.5 | 20.5 | 0.27 % | 45.0 % | 33.8 % | 1.00 |
Gujarat Terce Laboratories Ltd | 56.1 Cr. | 75.6 | 94.9/28.7 | 19.0 | 11.9 | 0.00 % | 9.72 % | 3.44 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 38.5 Cr. | 26.3 | 28.6/8.74 | 39.3 | 6.64 | 0.00 % | 2.65 % | 2.08 % | 10.0 |
Godavari Drugs Ltd | 67.8 Cr. | 90.0 | 155/87.0 | 11.0 | 55.4 | 0.00 % | 14.4 % | 15.5 % | 10.0 |
Glenmark Life Sciences Ltd | 13,316 Cr. | 1,084 | 1,335/666 | 31.4 | 207 | 2.07 % | 28.1 % | 21.1 % | 2.00 |
Gennex Laboratories Ltd | 288 Cr. | 12.6 | 29.0/11.5 | 16.6 | 7.93 | 0.00 % | 14.1 % | 10.2 % | 1.00 |
Ganga Pharmaceuticals Ltd | 8.22 Cr. | 17.0 | 27.1/13.3 | 164 | 14.6 | 0.00 % | 3.06 % | 0.80 % | 10.0 |
Fredun Pharmaceuticals Ltd | 326 Cr. | 694 | 1,054/635 | 17.4 | 278 | 0.10 % | 17.1 % | 14.3 % | 10.0 |
Fervent Synergies Ltd | 96.2 Cr. | 22.0 | 32.0/14.6 | | 8.11 | 0.00 % | 34.8 % | 34.9 % | 10.0 |
Fermenta Biotech Ltd | 880 Cr. | 299 | 449/145 | 25.0 | 98.6 | 0.42 % | 3.20 % | 5.59 % | 5.00 |
Fabino Enterprises Ltd | 6.09 Cr. | 29.0 | 39.6/23.6 | 122 | 20.0 | 0.00 % | 1.68 % | 1.21 % | 10.0 |
Evoq Remedies Ltd | 16.4 Cr. | 6.57 | 14.0/6.35 | 36.4 | 18.6 | 0.00 % | 1.91 % | 1.80 % | 10.0 |
Everest Organics Ltd | 243 Cr. | 250 | 307/110 | | 50.6 | 0.00 % | 6.05 % | 0.30 % | 10.0 |
Entero Healthcare Solutions Ltd | 5,358 Cr. | 1,231 | 1,584/970 | 59.5 | 387 | 0.00 % | 6.71 % | 4.98 % | 10.0 |
Murae Organisor Ltd | 172 Cr. | 1.85 | 2.72/1.03 | 36.5 | 2.85 | 0.00 % | 0.79 % | 0.13 % | 2.00 |
Dipna Pharmachem Ltd | 32.1 Cr. | 13.4 | 16.6/6.40 | 38.7 | 15.8 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
Decipher Labs Ltd | 12.5 Cr. | 12.4 | 24.6/12.0 | 54.4 | 21.3 | 0.00 % | 3.09 % | 6.75 % | 10.0 |
Coral Laboratories Ltd | 288 Cr. | 808 | 999/345 | 10.6 | 570 | 0.25 % | 12.6 % | 9.58 % | 10.0 |
Concord Drugs Ltd | 32.3 Cr. | 32.3 | 45.0/28.5 | | 33.9 | 0.00 % | 4.48 % | 1.28 % | 10.0 |
Colinz Laboratories Ltd | 21.4 Cr. | 46.8 | 84.4/36.0 | 43.6 | 20.5 | 0.00 % | 7.70 % | 5.73 % | 10.0 |
Cian Healthcare Ltd | 8.97 Cr. | 3.59 | 26.5/2.97 | 35.9 | 23.1 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 10.4 Cr. | 69.5 | 154/52.2 | 26.1 | 91.1 | 0.00 % | 13.3 % | 9.67 % | 10.0 |
Checkpoint Trends Ltd | 8.49 Cr. | 15.5 | 17.4/6.08 | | 0.93 | 0.00 % | 3.36 % | 5.77 % | 10.0 |
Chandra Bhagat Pharma Ltd | 47.6 Cr. | 63.0 | 145/60.0 | 30.1 | 39.4 | 0.00 % | 7.95 % | 5.42 % | 10.0 |
Brawn Biotech Ltd | 6.41 Cr. | 21.4 | 27.8/14.6 | | 14.1 | 0.00 % | 25.9 % | 21.8 % | 10.0 |
Blue Jet Healthcare Ltd | 12,526 Cr. | 723 | 845/329 | 53.4 | 53.3 | 0.14 % | 30.0 % | 22.4 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 95.0 Cr. | 22.0 | 36.3/21.7 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 17.1 Cr. | 33.7 | 46.0/26.0 | 214 | 18.3 | 0.00 % | 11.6 % | 8.95 % | 10.0 |
BDH Industries Ltd | 166 Cr. | 288 | 418/279 | 17.1 | 110 | 1.56 % | 20.6 % | 16.9 % | 10.0 |
Bacil Pharma Ltd | 25.8 Cr. | 43.7 | 62.6/8.15 | 73.6 | 2.87 | 0.00 % | 13.1 % | 13.8 % | 10.0 |
Aurobindo Pharma Ltd | 66,285 Cr. | 1,131 | 1,593/984 | 18.6 | 527 | 0.40 % | 14.1 % | 11.5 % | 1.00 |
Auro Laboratories Ltd | 131 Cr. | 210 | 307/137 | 37.6 | 69.6 | 0.00 % | 20.4 % | 20.5 % | 10.0 |
Anuh Pharma Ltd | 846 Cr. | 169 | 265/167 | 16.8 | 60.5 | 1.48 % | 25.6 % | 19.5 % | 5.00 |
ANG Lifesciences India Ltd | 49.6 Cr. | 38.0 | 68.7/36.6 | | 56.2 | 0.00 % | 1.78 % | 8.72 % | 10.0 |
Ami Organics Ltd | 8,871 Cr. | 2,164 | 2,644/1,004 | 73.0 | 294 | 0.14 % | 16.0 % | 9.37 % | 10.0 |
Amerise Biosciences Ltd | 5.95 Cr. | 0.90 | 1.45/0.55 | | 0.80 | 0.00 % | 2.73 % | 2.75 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 371 Cr. | 48.4 | 77.7/39.2 | 26.1 | 18.3 | 0.00 % | 7.08 % | 4.22 % | 10.0 |
Adline Chem Lab Ltd | 10.0 Cr. | 17.1 | 27.3/11.9 | | 2.70 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 99.4 Cr. | 4.22 | 6.25/2.87 | 151 | 1.32 | 0.00 % | 3.27 % | 2.52 % | 1.00 |
Abbott India Ltd | 59,135 Cr. | 27,840 | 30,683/25,200 | 44.3 | 1,657 | 1.47 % | 46.0 % | 34.9 % | 10.0 |
Aarti Pharmalabs Ltd | 6,539 Cr. | 719 | 771/381 | 26.2 | 205 | 0.42 % | 16.6 % | 13.1 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 122 Cr. | 44.5 | 75.8/37.0 | 17.6 | 48.5 | 0.00 % | 6.09 % | 3.74 % | 10.0 |
Zota Health Care Ltd | 2,412 Cr. | 880 | 1,078/440 | | 58.0 | 0.11 % | 7.32 % | 16.8 % | 10.0 |
Wockhardt Ltd | 22,460 Cr. | 1,385 | 1,680/446 | | 209 | 0.00 % | 0.83 % | 12.1 % | 5.00 |
Wanbury Ltd | 709 Cr. | 216 | 325/122 | 38.2 | 11.8 | 0.00 % | 60.6 % | % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 3.12 | 0.00 % | 9.38 % | 233 % | 2.00 |
Venus Remedies Ltd | 428 Cr. | 318 | 428/270 | 15.4 | 370 | 0.00 % | 8.57 % | 5.94 % | 10.0 |
Unichem Laboratories Ltd | 4,841 Cr. | 687 | 950/433 | 57.2 | 341 | 0.00 % | 0.39 % | 1.17 % | 2.00 |
TTK Healthcare Ltd | 1,716 Cr. | 1,205 | 1,923/1,190 | 25.0 | 735 | 0.83 % | 8.67 % | 6.43 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,01,981 Cr. | 3,014 | 3,591/2,488 | 54.8 | 222 | 0.93 % | 23.2 % | 24.2 % | 5.00 |
Themis Medicare Ltd | 1,744 Cr. | 189 | 317/181 | 37.8 | 44.8 | 0.27 % | 13.5 % | 11.8 % | 1.00 |
Syncom Formulations (India) Ltd | 1,653 Cr. | 17.6 | 27.9/11.0 | 43.4 | 3.32 | 0.00 % | 10.2 % | 8.51 % | 1.00 |
Suven Pharmaceuticals Ltd | 27,734 Cr. | 1,090 | 1,360/597 | 99.4 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
Suven Life Sciences Ltd | 2,536 Cr. | 116 | 169/83.0 | | 8.84 | 0.00 % | 36.4 % | 36.3 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 4,07,972 Cr. | 1,700 | 1,960/1,377 | 34.6 | 288 | 0.79 % | 17.3 % | 16.7 % | 1.00 |
Solara Active Pharma Sciences Ltd | 2,066 Cr. | 490 | 886/327 | | 301 | 0.00 % | 8.67 % | 33.5 % | 10.0 |
SMS Pharmaceuticals Ltd | 1,685 Cr. | 199 | 398/140 | 26.5 | 70.6 | 0.20 % | 11.2 % | 9.27 % | 1.00 |
SMS Lifesciences India Ltd | 388 Cr. | 1,293 | 1,750/551 | 18.4 | 621 | 0.12 % | 6.89 % | 3.66 % | 10.0 |
Shilpa Medicare Ltd | 6,354 Cr. | 650 | 960/372 | 75.1 | 238 | 0.00 % | 5.25 % | 1.71 % | 1.00 |
Sequent Scientific Ltd | 3,657 Cr. | 147 | 241/91.8 | 243 | 27.2 | 0.00 % | 0.44 % | 3.09 % | 2.00 |
Sanofi India Ltd | 11,884 Cr. | 5,150 | 7,600/4,606 | 28.2 | 298 | 3.24 % | 71.1 % | 51.5 % | 10.0 |
RPG Life Sciences Ltd | 3,700 Cr. | 2,242 | 2,977/1,360 | 38.7 | 229 | 0.71 % | 34.6 % | 25.5 % | 8.00 |
Procter & Gamble Health Ltd | 8,702 Cr. | 5,238 | 5,850/4,637 | 35.5 | 368 | 1.53 % | 45.0 % | 33.5 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 225 Cr. | 63.7 | 87.5/31.9 | | 19.0 | 0.00 % | 27.6 % | 16.8 % | 10.0 |
Pfizer Ltd | 19,159 Cr. | 4,178 | 6,453/3,950 | 31.1 | 820 | 0.84 % | 22.0 % | 16.1 % | 10.0 |
Par Drugs & Chemicals Ltd | 193 Cr. | 157 | 348/157 | 10.6 | 78.6 | 0.00 % | 25.0 % | 18.5 % | 10.0 |
Panacea Biotec Ltd | 2,064 Cr. | 336 | 491/112 | | 136 | 0.00 % | 3.57 % | 3.17 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 4,770 Cr. | 944 | 1,998/913 | 43.2 | 241 | 0.00 % | 9.37 % | 9.94 % | 10.0 |
Neuland Laboratories Ltd | 15,248 Cr. | 11,825 | 18,100/5,532 | 63.6 | 1,087 | 0.12 % | 33.3 % | 26.4 % | 10.0 |
Nectar Lifescience Ltd | 673 Cr. | 30.1 | 56.5/26.2 | 39.6 | 48.1 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
Natco Pharma Ltd | 15,846 Cr. | 883 | 1,639/868 | 8.50 | 399 | 1.08 % | 30.1 % | 25.9 % | 2.00 |
Morepen Laboratories Ltd | 2,836 Cr. | 51.8 | 101/38.6 | 22.5 | 20.3 | 0.00 % | 16.8 % | 12.0 % | 2.00 |
Marksans Pharma Ltd | 10,443 Cr. | 231 | 359/126 | 28.4 | 50.3 | 0.26 % | 20.6 % | 16.5 % | 1.00 |
Mangalam Drugs and Organics Ltd | 178 Cr. | 111 | 145/85.2 | 17.2 | 93.2 | 0.00 % | 1.19 % | 6.12 % | 10.0 |
Lyka Labs Ltd | 431 Cr. | 121 | 177/97.9 | 105 | 27.7 | 0.00 % | 3.53 % | 5.07 % | 10.0 |
Lupin Ltd | 89,905 Cr. | 1,970 | 2,403/1,493 | 31.3 | 343 | 0.41 % | 15.7 % | 14.1 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,125 Cr. | 562 | 980/498 | 12.6 | 319 | 0.32 % | 22.3 % | 16.8 % | 10.0 |
Laurus Labs Ltd | 29,456 Cr. | 546 | 646/372 | 118 | 79.2 | 0.15 % | 7.50 % | 5.43 % | 2.00 |
Kwality Pharmaceuticals Ltd | 784 Cr. | 755 | 1,070/405 | 22.2 | 234 | 0.00 % | 15.9 % | 13.7 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 176 Cr. | 82.1 | 129/60.0 | | 60.4 | 0.00 % | 19.0 % | % | 10.0 |
Kopran Ltd | 795 Cr. | 164 | 370/162 | 16.7 | 103 | 1.83 % | 13.8 % | 11.0 % | 10.0 |
Kilitch Drugs (India) Ltd | 503 Cr. | 311 | 435/294 | 28.1 | 118 | 0.00 % | 12.6 % | 7.71 % | 10.0 |
Jubilant Pharmova Ltd | 15,076 Cr. | 945 | 1,310/538 | 45.2 | 373 | 0.53 % | 6.74 % | 0.76 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 25,946 Cr. | 1,669 | 2,030/1,474 | 40.5 | 207 | 0.73 % | 24.6 % | 20.0 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,520 Cr. | 230 | 328/108 | 41.7 | 29.7 | 0.87 % | 17.0 % | 13.0 % | 2.00 |
Ipca Laboratories Ltd | 37,124 Cr. | 1,464 | 1,758/1,052 | 50.6 | 264 | 0.27 % | 12.8 % | 9.35 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 1,974 Cr. | 336 | 538/331 | 20.2 | 283 | 1.49 % | 12.3 % | 8.68 % | 10.0 |
Ind-Swift Ltd | 78.9 Cr. | 14.6 | 34.7/13.6 | 1.22 | 122 | 0.00 % | 13.4 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 542 Cr. | 91.9 | 186/85.1 | 6.55 | 171 | 0.00 % | 19.6 % | 17.4 % | 10.0 |
Indoco Remedies Ltd | 2,269 Cr. | 246 | 388/242 | | 118 | 0.61 % | 10.4 % | 8.33 % | 2.00 |
Hikal Ltd | 4,217 Cr. | 342 | 465/260 | 56.6 | 97.6 | 0.35 % | 7.79 % | 5.97 % | 2.00 |
Hester Biosciences Ltd | 1,444 Cr. | 1,683 | 3,379/1,293 | 46.7 | 355 | 0.36 % | 9.32 % | 6.60 % | 10.0 |
Gufic BioSciences Ltd | 4,006 Cr. | 402 | 504/278 | 47.2 | 57.3 | 0.02 % | 17.2 % | 20.0 % | 1.00 |
Granules India Ltd | 12,428 Cr. | 513 | 725/382 | 25.9 | 141 | 0.29 % | 15.4 % | 13.4 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 37,369 Cr. | 1,323 | 1,831/822 | | 299 | 0.19 % | 12.3 % | 50.9 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 34,240 Cr. | 2,018 | 3,088/1,825 | 40.1 | 98.7 | 1.59 % | 51.3 % | 37.3 % | 10.0 |
Gland Pharma Ltd | 23,960 Cr. | 1,459 | 2,221/1,411 | 21.4 | 557 | 1.37 % | 16.7 % | 12.3 % | 1.00 |
FDC Ltd | 6,615 Cr. | 405 | 659/399 | 24.1 | 141 | 1.23 % | 18.4 % | 14.2 % | 1.00 |
ERIS Lifesciences Ltd | 17,008 Cr. | 1,249 | 1,594/809 | 51.6 | 204 | 0.59 % | 11.3 % | 16.3 % | 1.00 |
Dr Reddys Laboratories Ltd | 99,909 Cr. | 1,197 | 1,421/1,120 | 18.6 | 369 | 0.67 % | 26.5 % | 21.4 % | 1.00 |
Dishman Carbogen Amcis Ltd | 3,187 Cr. | 203 | 308/133 | | 366 | 0.00 % | 0.02 % | 2.64 % | 2.00 |
Cipla Ltd | 1,17,871 Cr. | 1,459 | 1,702/1,317 | 23.7 | 351 | 0.89 % | 22.8 % | 16.8 % | 2.00 |
Caplin Point Laboratories Ltd | 14,590 Cr. | 1,916 | 2,641/1,221 | 28.3 | 334 | 0.26 % | 26.5 % | 24.2 % | 2.00 |
Brooks Laboratories Ltd | 353 Cr. | 134 | 203/72.5 | | 22.6 | 0.00 % | 24.7 % | 28.1 % | 10.0 |
Bliss GVS Pharma Ltd | 1,387 Cr. | 132 | 186/92.2 | 16.4 | 95.8 | 0.38 % | 14.4 % | 10.2 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 81.7 Cr. | 51.0 | 92.0/49.0 | 136 | 11.3 | 0.00 % | 4.94 % | 4.00 % | 10.0 |
Biocon Ltd | 41,931 Cr. | 349 | 405/244 | 50.9 | 175 | 0.14 % | 5.96 % | 5.25 % | 5.00 |
Beta Drugs Ltd | 1,711 Cr. | 1,779 | 2,326/1,060 | 41.7 | 188 | 0.00 % | 32.8 % | 26.0 % | 10.0 |
Bal Pharma Ltd | 156 Cr. | 96.9 | 158/89.0 | 21.5 | 43.2 | 1.24 % | 12.1 % | 11.0 % | 10.0 |
Bafna Pharmaceuticals Ltd | 176 Cr. | 74.7 | 113/73.2 | 37.7 | 35.0 | 0.00 % | 9.48 % | 9.44 % | 10.0 |
Astrazeneca Pharma India Ltd | 17,722 Cr. | 7,104 | 8,140/4,050 | 106 | 272 | 0.34 % | 31.1 % | 22.9 % | 2.00 |
Amrutanjan Health Care Ltd | 1,762 Cr. | 612 | 863/591 | 35.7 | 103 | 0.75 % | 21.3 % | 15.5 % | 1.00 |
Alpa Laboratories Ltd | 222 Cr. | 106 | 145/69.9 | 8.83 | 83.0 | 0.00 % | 13.7 % | 11.2 % | 10.0 |
Alkem Laboratories Ltd | 55,583 Cr. | 4,652 | 6,440/4,407 | 25.7 | 961 | 0.86 % | 19.7 % | 19.6 % | 2.00 |
Alembic Pharmaceuticals Ltd | 16,073 Cr. | 818 | 1,304/802 | 27.1 | 249 | 1.34 % | 13.1 % | 13.3 % | 2.00 |
Albert David Ltd | 485 Cr. | 852 | 1,754/834 | 12.0 | 724 | 1.35 % | 27.8 % | 21.7 % | 10.0 |
Ajanta Pharma Ltd | 32,009 Cr. | 2,560 | 3,486/1,998 | 35.6 | 294 | 1.41 % | 31.6 % | 23.2 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,450 Cr. | 309 | 571/301 | 24.2 | 120 | 1.65 % | 15.2 % | 11.2 % | 2.00 |
Aarti Drugs Limited | 3,780 Cr. | 412 | 635/370 | 28.6 | 126 | 0.24 % | 13.7 % | 12.4 % | 10.0 |
Industry Average | 17,485.00 Cr | 1,053.35 | | 43.94 | 185.20 | 0.37% | 16.18% | 16.43% | 6.27 |